Michael Duchowny
Neurology with Special Qualifications in Child Neurology · Miami, FLNPI 1619934338
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,260 of the $9,945 with a category attached, or 62.9%. Mallinckrodt Enterprises LLC accounts for 71.9% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $7,715 and has fallen 89.1% since, to $840 in 2023.
Across 130 payments — averaging $76.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Enterprises LLC$7K
- Jazz Pharmaceuticals Inc.$628
- UCB, Inc.$609
- Supernus Pharmaceuticals, Inc.$322
- Livanova USA, Inc.$259
- Aquestive Therapeutics, Inc.$126
- plus $849 from 18 others
What the payments were for
- Consulting fees$6,26063%
- Travel & lodging$8098%
- Food & beverage$2,87529%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Enterprises LLC | 8 | $7,153 |
| Jazz Pharmaceuticals Inc. | 14 | $628 |
| UCB, Inc. | 18 | $609 |
| Supernus Pharmaceuticals, Inc. | 30 | $322 |
| Livanova USA, Inc. | 8 | $259 |
| Aquestive Therapeutics, Inc. | 6 | $126 |
| Neurelis, Inc. | 7 | $121 |
| SK Life Science, Inc. | 4 | $95 |
| Corium, LLC | 5 | $88 |
| Eisai Inc. | 5 | $86 |
| Sunovion Pharmaceuticals Inc. | 4 | $77 |
| Novartis | 3 | $47 |
| Ironshore Pharmaceuticals Inc. | 3 | $47 |
| Greenwich Biosciences, Inc. | 3 | $45 |
| Immedica Pharma US, Inc. | 2 | $42 |
| Aprecia Pharmaceuticals, LLC | 2 | $31 |
| AbbVie | 1 | $28 |
| Sarepta Therapeutics, Inc. | 1 | $26 |
| Biogen | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Neuropace, Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Tris Pharma Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTHAR$7,034
- Epidiolex$139
- VNS Therapy$122
How this compares
$9,945 in reported general payments places this provider in the 70th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in Miami
- Trevor ResnickMiami$230K
- Migvis MonduyMiami$188K
- Elza VasconcellosMiami$170K
- Ian MillerMiami$104K
- Matt LallasMiami$88K
- Marytery FajardoMiami$44K
- Paula SchleiferMiami$31K
- Roberto Lopez-AlberolaMiami$31K
- Anuj JayakarMiami$24K
- Walter BradleyMiami$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.